Hiroshi Maeda

3PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Characterisation of biological macromoleculesMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 07, 2021
Development of a Selective Tumor-Targeted Drug Delivery System: Hydroxypropyl-Acrylamide Polymer-Conjugated Pirarubicin (P-THP) for Pediatric Solid Tumors.

Atsushi Makimoto, Jun Fang, Hiroshi Maeda

|Dec 30, 2020
Phosphorylcholine-Grafted Molecular Bottlebrush-Doxorubicin Conjugates: High Structural Stability, Long Circulation in Blood, and Efficient Anticancer Activity.

Shin Takano, Waliul Islam, Kohji Nakazawa

|Jul 12, 2019
Superior Penetration and Cytotoxicity of HPMA Copolymer Conjugates of Pirarubicin in Tumor Cell Spheroid.

Hideaki Nakamura, Eva Koziolová, Petr Chytil

Pageof 1

Frequent Collaborators

1 joint publications

Hideaki Nakamura

1 joint publications

Tomáš Etrych

1 joint publications

Kazuo Sakurai

1 joint publications

Shota Fujii